systemic sclerosis treatment | Overview of the treatment and prognosis

Keyword	CPC	PCC	Volume	Score	Length of keyword
systemic sclerosis treatment	1.16	0.9	5203	46	28
systemic	0.01	0.6	2627	42	8
sclerosis	1.86	0.4	6955	2	9
treatment	0.39	0.9	3429	67	9

Keyword	CPC	PCC	Volume	Score
systemic sclerosis treatment	0.58	0.1	6178	94
systemic sclerosis treatment guidelines	0.73	0.3	6801	15
systemic sclerosis treatment options	0.9	1	9577	59
systemic sclerosis treatment drugs	0.55	0.1	9259	6
systemic sclerosis treatment guidelines acr	1.09	0.9	1468	1
systemic sclerosis treatment in india	0.21	0.6	4185	49
systemic sclerosis treatment in homeopathy	0.81	0.3	5668	2
limited systemic sclerosis treatment	1.26	0.4	2300	69
progressive systemic sclerosis treatment	1.98	0.4	32	100
systemic sclerosis new treatment	0.35	0.4	5163	83

Search Results related to systemic sclerosis treatment on Search Engine

Overview of the treatment and prognosis of systemic sclerosis
uptodate.com

https://www.uptodate.com/contents/overview-of-the-treatment-and-prognosis-of-systemic-sclerosis-scleroderma-in-adults

WEBAug 28, 2023 · As a result, treatment of these conditions is difficult, incomplete, and not curative. (See "Risk factors for and possible causes of systemic sclerosis (scleroderma)" and "Pathogenesis of systemic sclerosis (scleroderma)" .) An overview of the management of adults with SSc will be discussed here.

DA: 63 PA: 98 MOZ Rank: 20

Systemic Sclerosis - Bone, Joint, and Muscle Disorders - Merck …
merckmanuals.com

https://www.merckmanuals.com/home/bone,-joint,-and-muscle-disorders/autoimmune-disorders-of-connective-tissue/systemic-sclerosis

WEBThere is no cure for systemic sclerosis, but symptoms and organ dysfunction can be treated. Systemic sclerosis causes an overproduction of collagen and other proteins in various tissues. The cause of systemic sclerosis is not known. The disorder is 4 times more common among women and most common among people aged 20 to 50.

DA: 2 PA: 53 MOZ Rank: 32

Scleroderma - Diagnosis and treatment - Mayo Clinic
mayoclinic.org

https://www.mayoclinic.org/diseases-conditions/scleroderma/diagnosis-treatment/drc-20351957

WEBJan 27, 2022 · Treatment. There is no treatment that can cure or stop the overproduction of collagen that is characteristic of scleroderma. But a variety of treatments can help control symptoms and prevent complications. Medications. Because scleroderma can affect so many different parts of the body, the choice of medication will vary, depending …

DA: 25 PA: 1 MOZ Rank: 64

State-of-the-art evidence in the treatment of systemic sclerosis
nature.com

https://www.nature.com/articles/s41584-023-00909-5

WEBFeb 27, 2023 · Treatment of pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc) is guided by risk stratification, which uses information from clinical assessments and imaging.

DA: 41 PA: 78 MOZ Rank: 63

Scleroderma - Symptoms and causes - Mayo Clinic
mayoclinic.org

https://www.mayoclinic.org/diseases-conditions/scleroderma/symptoms-causes/syc-20351952

WEBJan 27, 2022 · Scleroderma (sklair-oh-DUR-muh), also known as systemic sclerosis, is a group of rare diseases that involve the hardening and tightening of the skin. It may also cause problems in the blood vessels, internal organs and digestive tract. Scleroderma is often categorized as "limited" or "diffuse," which refers only to the degree of skin …

DA: 23 PA: 55 MOZ Rank: 38

Scleroderma Clinic - Overview - Mayo Clinic
mayoclinic.org

https://www.mayoclinic.org/departments-centers/scleroderma-clinic/overview/ovc-20478748

WEBApr 1, 2020 · The Scleroderma Clinic specializes in providing comprehensive care for people with scleroderma and related conditions. Scleroderma, also called systemic sclerosis, is a complex autoimmune disease that can …

DA: 72 PA: 5 MOZ Rank: 89

Current Advances in the Treatment of Systemic Sclerosis - PMC
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466985/

WEBSystemic sclerosis (SSc; scleroderma) is a rare, chronic connective tissue disease of unknown etiology that portends the highest case-specific mortality among the systemic rheumatic diseases . While pathologic vasculopathy, immune dysregulation and fibrosis uniquely contribute to organ damage in SSc, there is considerable variability …

DA: 96 PA: 82 MOZ Rank: 28

Scleroderma Treatment Options - Johns Hopkins Scleroderma …
hopkinsscleroderma.org

https://www.hopkinsscleroderma.org/patients/scleroderma-treatment-options/

WEBThe most promising drugs are mycophenolate mofetil or cyclophosphamide with or without antithymocyte globulin.

DA: 13 PA: 8 MOZ Rank: 42

Scleroderma Treatment | Johns Hopkins Medicine
hopkinsmedicine.org

https://www.hopkinsmedicine.org/health/conditions-and-diseases/scleroderma/scleroderma-treatment

WEBPlateaus. Some patients may have a time when their condition stabilizes. During this time, your skin may improve, and the mobility could increase. This could be a short-term change or might even go into long-term remission. Monitoring. Patients with systemic scleroderma should be screened regularly to monitor for internal organ complications.

DA: 99 PA: 19 MOZ Rank: 23

Systemic Sclerosis - Musculoskeletal and Connective Tissue …
merckmanuals.com

https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/autoimmune-rheumatic-disorders/systemic-sclerosis

WEBPathophysiology |. Symptoms and Signs |. Diagnosis |. Prognosis |. Treatment |. Key Points. Systemic sclerosis is a rare chronic disease of unknown cause characterized by diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs (especially the esophagus, lower gastrointestinal tract, lungs, heart, and kidneys).

DA: 68 PA: 32 MOZ Rank: 4